| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2daf6d7a06768f0db6ce61cf2f44ece2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L75-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 |
| filingDate |
2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1a47bf6feeea60758f88333ae31e954
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21e99b18d5d1b85766acbc094b3f3439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d92819bd3e6022b7488b6cd999254b4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5be2b8c3d279f4caa594f45fa08f230
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acdfa2e1ad7bc3f73d13f4ad04d7be33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bfd55dd930a1098544117a0d71ead9b |
| publicationDate |
2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017298112-A1 |
| titleOfInvention |
Peptide-oligourea foldamer compounds and methods of their use |
| abstract |
The present description provides compositions and methods for producing therapeutic compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the present disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285219-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020108830-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020148317-A1 |
| priorityDate |
2016-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |